BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10193953)

  • 1. Central neurocytoma: histologic atypia, proliferation potential, and clinical outcome.
    Mackenzie IR
    Cancer; 1999 Apr; 85(7):1606-10. PubMed ID: 10193953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of proliferative potentiality of central neurocytoma: correlational analysis of minimum ADC and maximum SUV with MIB-1 labeling index.
    Sakamoto R; Okada T; Kanagaki M; Yamamoto A; Fushimi Y; Kakigi T; Arakawa Y; Takahashi JC; Mikami Y; Togashi K
    Acta Radiol; 2015 Jan; 56(1):114-20. PubMed ID: 24477268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two cases of atypical central neurocytomas.
    Kuchiki H; Kayama T; Sakurada K; Saino M; Kawakami K; Sato S
    Brain Tumor Pathol; 2002; 19(2):105-10. PubMed ID: 12622142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central, Extraventricular and Atypical Neurocytomas: a Clinicopathologic Study of 35 Cases from Pakistan Plus a Detailed Review of the Published Literature.
    Ahmad Z; Din NU; Memon A; Tariq MU; Idrees R; Hasan S
    Asian Pac J Cancer Prev; 2016; 17(3):1565-70. PubMed ID: 27039806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extraventricular neurocytomas: pathologic features and clinical outcome.
    Brat DJ; Scheithauer BW; Eberhart CG; Burger PC
    Am J Surg Pathol; 2001 Oct; 25(10):1252-60. PubMed ID: 11688459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 and MIB-1 immunohistochemistry in ependymomas: a study of 41 cases.
    Prayson RA
    Am J Clin Pathol; 1998 Nov; 110(5):629-34. PubMed ID: 9802348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular proliferation in pilocytic and diffuse astrocytomas.
    Giannini C; Scheithauer BW; Burger PC; Christensen MR; Wollan PC; Sebo TJ; Forsyth PA; Hayostek CJ
    J Neuropathol Exp Neurol; 1999 Jan; 58(1):46-53. PubMed ID: 10068313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic study of 61 patients with ependymoma including MIB-1 immunohistochemistry.
    Prayson RA
    Ann Diagn Pathol; 1999 Feb; 3(1):11-8. PubMed ID: 9990108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (201)Tl-SPECT, (1)H-MRS, and MIB-1 labeling index of central neurocytomas: three case reports.
    Kanamori M; Kumabe T; Shimizu H; Yoshimoto T
    Acta Neurochir (Wien); 2002 Feb; 144(2):157-63; discussion 163. PubMed ID: 11862516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathological variants of central neurocytoma: Report of 10 cases.
    Favereaux A; Vital A; Loiseau H; Dousset V; Caille J; Petry K
    Ann Pathol; 2000 Dec; 20(6):558-63. PubMed ID: 11148351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric Central Neurocytoma.
    Karthigeyan M; Gupta K; Salunke P
    J Child Neurol; 2017 Jan; 32(1):53-59. PubMed ID: 27664193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical central neurocytoma.
    Söylemezoglu F; Scheithauer BW; Esteve J; Kleihues P
    J Neuropathol Exp Neurol; 1997 May; 56(5):551-6. PubMed ID: 9143268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of proliferative markers in central neurocytoma.
    Sharma MC; Rathore A; Karak AK; Sarkar C
    Pathology; 1998 Nov; 30(4):355-9. PubMed ID: 9839309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferative activity of central neurocytoma: measurement of tumor volume doubling time, MIB-1 staining index and bromodeoxyuridine labeling index.
    Fujimaki T; Matsuno A; Sasaki T; Toyoda T; Matsuura R; Ogai M; Kitanaka C; Asai A; Matsutani M; Kirino T
    J Neurooncol; 1997 Apr; 32(2):103-9. PubMed ID: 9120539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypia predicting prognosis for intracranial extraventricular neurocytomas.
    Kane AJ; Sughrue ME; Rutkowski MJ; Aranda D; Mills SA; Lehil M; Fang S; Parsa AT
    J Neurosurg; 2012 Feb; 116(2):349-54. PubMed ID: 22054208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MIB-1 staining index of pediatric meningiomas.
    Sandberg DI; Edgar MA; Resch L; Rutka JT; Becker LE; Souweidane MM
    Neurosurgery; 2001 Mar; 48(3):590-5; discussion 595-7. PubMed ID: 11270550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central neurocytomas with MIB-1 labeling index over 10% showing rapid tumor growth and dissemination.
    Ogawa Y; Sugawara T; Seki H; Sakuma T
    J Neurooncol; 2006 Sep; 79(2):211-6. PubMed ID: 16552620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical Neurocytoma: Dilemma in diagnosis and management.
    Vajrala G; Jain PK; Surana S; Madigubba S; Immaneni SR; Panigrahi MK
    Surg Neurol Int; 2014; 5():183. PubMed ID: 25593767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ependymomas: MIB-1 proliferation index and survival.
    Ritter AM; Hess KR; McLendon RE; Langford LA
    J Neurooncol; 1998 Oct; 40(1):51-7. PubMed ID: 9874186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinico-radiological characteristics, histo-pathological features and long-term survival outcomes in central neurocytoma: A single-institutional audit.
    Pawar D; Chatterjee A; Epari S; Sahay A; Janu A; Krishnatry R; Goda JS; Shetty P; Moiyadi A; Gupta T
    J Clin Neurosci; 2021 Feb; 84():91-96. PubMed ID: 33358093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.